Michael Robbins

4.7k total citations · 1 hit paper
104 papers, 2.8k citations indexed

About

Michael Robbins is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Michael Robbins has authored 104 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 18 papers in Immunology and 16 papers in Molecular Biology. Recurrent topics in Michael Robbins's work include Multiple Myeloma Research and Treatments (20 papers), Immune Cell Function and Interaction (14 papers) and Psychotherapy Techniques and Applications (11 papers). Michael Robbins is often cited by papers focused on Multiple Myeloma Research and Treatments (20 papers), Immune Cell Function and Interaction (14 papers) and Psychotherapy Techniques and Applications (11 papers). Michael Robbins collaborates with scholars based in United States, Germany and Japan. Michael Robbins's co-authors include Mark Tessler, John Hambor, Leslie J. Francis, Mark J. Neveu, James M. Duerr, Craig B. Thompson, Ellen Chuang, Paul G. Richardson, Suresh G. Shelat and Matthew G. Vander Heiden and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Blood.

In The Last Decade

Michael Robbins

97 papers receiving 2.6k citations

Hit Papers

Elotuzumab plus Pomalidomide and Dexamethasone for Multip... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma
    2018 364 citations Paul G. Richardson, Suresh G. Shelat et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Robbins United States 27 942 920 874 811 286 104 2.8k
Robert J. Kelly United States 30 343 0.4× 2.0k 2.2× 335 0.4× 1.1k 1.4× 427 1.5× 118 4.6k
Jennifer Garst United States 30 1.4k 1.5× 1.2k 1.3× 335 0.4× 359 0.4× 520 1.8× 69 4.0k
Kevin R. Kelly United States 40 1.3k 1.3× 2.1k 2.3× 705 0.8× 330 0.4× 131 0.5× 172 4.7k
Jōhn W. Parker United States 32 549 0.6× 560 0.6× 262 0.3× 721 0.9× 189 0.7× 108 3.1k
Francisco J. Medina Spain 31 382 0.4× 310 0.3× 156 0.2× 683 0.8× 500 1.7× 171 3.8k
Lesley Murray United Kingdom 33 1.5k 1.6× 2.2k 2.4× 939 1.1× 731 0.9× 304 1.1× 94 5.4k
Louise Kelly Ireland 27 436 0.5× 1.2k 1.3× 1.3k 1.4× 856 1.1× 514 1.8× 68 4.1k
David R. Archer United States 32 376 0.4× 1.7k 1.8× 704 0.8× 822 1.0× 235 0.8× 115 5.1k
Arthur M. Cohen United States 25 435 0.5× 759 0.8× 334 0.4× 285 0.4× 209 0.7× 215 3.7k
Barbara Sullivan United States 27 450 0.5× 1.0k 1.1× 90 0.1× 1.4k 1.7× 291 1.0× 66 3.0k

Countries citing papers authored by Michael Robbins

Since Specialization
Citations

This map shows the geographic impact of Michael Robbins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Robbins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Robbins more than expected).

Fields of papers citing papers by Michael Robbins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Robbins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Robbins. The network helps show where Michael Robbins may publish in the future.

Co-authorship network of co-authors of Michael Robbins

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Robbins. A scholar is included among the top collaborators of Michael Robbins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Robbins. Michael Robbins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ledzewicz, Urszula, et al.. (2023). Determining optimal combination regimens for patients with multiple myeloma. European Journal of Pharmaceutical Sciences. 187. 106492–106492. 4 indexed citations
2.
Robbins, Michael & David Grant. (2020). RAND American Educator Panels Technical Description. RAND Corporation eBooks. 28 indexed citations
3.
Ghobrial, Irene M., Chia‐Jen Liu, Robert Redd, et al.. (2019). A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma. Clinical Cancer Research. 26(2). 344–353. 79 indexed citations
4.
Pazina, Tatiana, Ashley M. James, Yibin Yang, et al.. (2019). Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma. Cancer Immunology Research. 7(10). 1633–1646. 34 indexed citations
5.
Kurdi, Ahmed T., Siobhan Glavey, Natalie Bezman, et al.. (2018). Antibody-Dependent Cellular Phagocytosis by Macrophages is a Novel Mechanism of Action of Elotuzumab. Molecular Cancer Therapeutics. 17(7). 1454–1463. 70 indexed citations
6.
Gallaher, Jill, Marissa Renardy, Nessy Tania, et al.. (2018). Methods for determining key components in a mathematical model for tumor–immune dynamics in multiple myeloma. Journal of Theoretical Biology. 458. 31–46. 14 indexed citations
7.
Iida, Shinsuke, Hirokazu Nagai, Michael Robbins, et al.. (2016). Elotuzumab with lenalidomide and dexamethasone for Japanese patients with relapsed/refractory multiple myeloma: phase 1 study. International Journal of Hematology. 105(3). 326–334. 6 indexed citations
8.
Postelnek, Jennifer, Robert Neely, Michael Robbins, et al.. (2016). Development and Validation of Electrochemiluminescence Assays to Measure Free and Total sSLAMF7 in Human Serum in the Absence and Presence of Elotuzumab. The AAPS Journal. 18(4). 989–999. 5 indexed citations
9.
Robbins, Michael, et al.. (2014). Searching for Stability: The Arab Barometer Surveys a Divided Libya. 1 indexed citations
10.
Robbins, Michael. (2012). The Successful Psychoanalytic Therapy of a Schizophrenic Woman. Psychodynamic Psychiatry. 40(4). 575–608. 2 indexed citations
11.
Robbins, Michael. (2011). Islam is Not the Solution: The Challenge Islamist Parties Face Mobilizing Support on Economic Issues. SSRN Electronic Journal. 1 indexed citations
12.
Robbins, Michael. (2009). What Accounts for Popular Support for Islamist Parties in the Arab World? Evidence from the Arab Barometer. SSRN Electronic Journal. 4 indexed citations
13.
Francis, Leslie J. & Michael Robbins. (2008). Mental Health, Religion & Culture. Journal of Psychology and Theology. 36(4). 314. 87 indexed citations
14.
Robbins, Michael, Stephen F. Petras, James J. Valentine, et al.. (2008). Pharmacologic Inhibition of Site 1 Protease Activity Inhibits Sterol Regulatory Element-Binding Protein Processing and Reduces Lipogenic Enzyme Gene Expression and Lipid Synthesis in Cultured Cells and Experimental Animals. Journal of Pharmacology and Experimental Therapeutics. 326(3). 801–808. 108 indexed citations
15.
Hay, Bruce A., James J. Valentine, Stephen F. Petras, et al.. (2007). Aminopyrrolidineamide inhibitors of site-1 protease. Bioorganic & Medicinal Chemistry Letters. 17(16). 4411–4414. 70 indexed citations
16.
Robbins, Michael. (2002). THE LANGUAGE OF SCHIZOPHRENIA AND THE WORLD OF DELUSION. The International Journal of Psychoanalysis. 83(2). 383–405. 2 indexed citations
17.
Robbins, Michael. (2001). Histoire De L'electricite En Suisse: La Dynamique D'un Petit Pays Europeen 1875-1939. 22(2). 163. 4 indexed citations
18.
Chuang, Ellen, Kyung‐Mi Lee, Michael Robbins, et al.. (1999). Regulation of Cytotoxic T Lymphocyte-Associated Molecule-4 by Src Kinases. The Journal of Immunology. 162(3). 1270–1277. 98 indexed citations
19.
Robbins, Michael. (1982). Narcissistic personality as a symbiotic character disorder.. PubMed. 63(Pt 4). 457–73. 9 indexed citations
20.
Robbins, Michael. (1966). George and Robert Stephenson. Oxford University Press eBooks. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert J. Kelly Breakdown of academic impact, for papers by Jennifer Garst Breakdown of academic impact, for papers by Kevin R. Kelly Breakdown of academic impact, for papers by Jōhn W. Parker Breakdown of academic impact, for papers by Francisco J. Medina Breakdown of academic impact, for papers by Lesley Murray Breakdown of academic impact, for papers by Louise Kelly Breakdown of academic impact, for papers by David R. Archer Breakdown of academic impact, for papers by Arthur M. Cohen Breakdown of academic impact, for papers by Barbara Sullivan
Rankless by CCL
2026